BeStock  
Stocks › Biotechnology › BBIO

BridgeBio Pharma BBIO

US equityMarket cap rank #1114Biotechnology
$76.03 −$2.15 (-2.75%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $76.03 0.00%
Open$77.85
Prev close$78.18
Day range$75.46 – $78.24
Volume1.48M
Market cap$14.81B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts16
Average target$110.00+44.7% vs. price
  • Buy 94%
  • Hold 6%
Low $91.00Now $76.03Avg $110.00High $156.00

Recent rating changes

The last 20 actions on file set price targets from $87.00 to $156.00, averaging $104.58.

DateFirmRatingTarget
20 Nov 2026 Piper Sandler BUY $120.00
13 Nov 2026 Morgan Stanley BUY $91.00
2 Nov 2026 CCORF BUY $108.00
2 Nov 2026 Barclays BUY $156.00
30 Oct 2026 Wells Fargo BUY $102.00
30 Oct 2026 UBS BUY $92.00
30 Oct 2026 Piper Sandler BUY $120.00
30 Oct 2026 BofA Securities BUY –
30 Oct 2026 Morgan Stanley BUY $88.00
30 Oct 2026 Evercore BUY $130.00
30 Oct 2026 Citi HOLD $91.00
30 Oct 2026 RBC Capital BUY $100.00
29 Oct 2026 TD Cowen BUY $100.00
29 Oct 2026 Cantor Fitzgerald BUY $110.00
29 Oct 2026 Wells Fargo BUY $102.00
25 Oct 2026 Cantor Fitzgerald BUY $110.00
22 Oct 2026 Morgan Stanley BUY $87.00
21 Oct 2026 Morgan Stanley BUY $87.00
20 Oct 2026 Citi HOLD $91.00
19 Oct 2026 BofA Securities BUY $102.00

Discussion

No comments yet — be the first to weigh in on BBIO.

Sign in to join the discussion.

Scroll to Top